389 related articles for article (PubMed ID: 11754411)
21. A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.
Nucci M; Biasoli I; Akiti T; Silveira F; Solza C; Barreiros G; Spector N; Derossi A; Pulcheri W
Clin Infect Dis; 2000 Feb; 30(2):300-5. PubMed ID: 10671332
[TBL] [Abstract][Full Text] [Related]
22. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
[TBL] [Abstract][Full Text] [Related]
23. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
Soubani AO; Qureshi MA
Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117
[TBL] [Abstract][Full Text] [Related]
24. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients.
Böhme A; Hoelzer D
Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997
[TBL] [Abstract][Full Text] [Related]
25. Invasive pulmonary aspergillosis prior to BMT in acute leukemia patients does not predict a poor outcome.
Richard C; Romón I; Baro J; Insunza A; Loyola I; Zurbano F; Tapia M; Iriondo A; Conde E; Zubizarreta A
Bone Marrow Transplant; 1993 Sep; 12(3):237-41. PubMed ID: 8241983
[TBL] [Abstract][Full Text] [Related]
26. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).
Pagano L; Ricci P; Tonso A; Nosari A; Cudillo L; Montillo M; Cenacchi A; Pacilli L; Fabbiano F; Del Favero A
Br J Haematol; 1997 Nov; 99(2):331-6. PubMed ID: 9375750
[TBL] [Abstract][Full Text] [Related]
27. [Invasive Aspergillosis in Hematological Patients].
Kimura S
Med Mycol J; 2016; 57(2):J77-88. PubMed ID: 27251320
[TBL] [Abstract][Full Text] [Related]
28. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Lortholary O; Meyohas MC; Dupont B; Cadranel J; Salmon-Ceron D; Peyramond D; Simonin D
Am J Med; 1993 Aug; 95(2):177-87. PubMed ID: 8395142
[TBL] [Abstract][Full Text] [Related]
29. Invasive Aspergillosis among Haematological Malignancy Patients in Ghana: A Pilot Study on Prevalence and Antifungal Prophylaxis at the National Referral Hospital.
Ocansey BK; Otoo B; Gbadamosi H; Opintan JA; Dei-Adomakoh Y; Kosmidis C; Denning DW
West Afr J Med; 2023 Jun; 40(6):613-618. PubMed ID: 37390225
[TBL] [Abstract][Full Text] [Related]
30. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
[TBL] [Abstract][Full Text] [Related]
31. Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients.
Jeffery GM; Beard ME; Ikram RB; Chua J; Allen JR; Heaton DC; Hart DN; Schousboe MI
Am J Med; 1991 Jun; 90(6):685-92. PubMed ID: 2042684
[TBL] [Abstract][Full Text] [Related]
32. [Invasive aspergillosis in hematological patients].
Rask CU; Peterslund NA
Ugeskr Laeger; 2000 Feb; 162(6):773-7. PubMed ID: 10689950
[TBL] [Abstract][Full Text] [Related]
33. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
[TBL] [Abstract][Full Text] [Related]
34. Invasive aspergillosis in a paediatric haematology department: a 15-year review.
Crassard N; Hadden H; Piens MA; Pondarré C; Hadden R; Galambrun C; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
Mycoses; 2008 Mar; 51(2):109-16. PubMed ID: 18254746
[TBL] [Abstract][Full Text] [Related]
35. High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia.
Lafaurie M; Lapalu J; Raffoux E; Breton B; Lacroix C; Socié G; Porcher R; Ribaud P; Touratier S; Molina JM
Clin Microbiol Infect; 2010 Aug; 16(8):1191-6. PubMed ID: 19735276
[TBL] [Abstract][Full Text] [Related]
36. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
[TBL] [Abstract][Full Text] [Related]
37. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
[TBL] [Abstract][Full Text] [Related]
38. Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study.
Kelsey SM; Goldman JM; McCann S; Newland AC; Scarffe JH; Oppenheim BA; Mufti GJ
Bone Marrow Transplant; 1999 Jan; 23(2):163-8. PubMed ID: 10197802
[TBL] [Abstract][Full Text] [Related]
39. [Fever and cavitary infiltrate in a renal transplant recipient].
Rocamora N; Tormo AM; Franco A; Alvarez Avellán L; Olivares J
Nefrologia; 2004; 24 Suppl 3():16-20. PubMed ID: 15219062
[TBL] [Abstract][Full Text] [Related]
40. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
